Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial
Lucia Musacchio, Margherita Turinetto, Laura Arenare, Michele Bartoletti, Daniela Califano, Valentina Tuninetti, Cláudia Marchetti, Gennaro Cormio, Vera Loizzi, Carmela Pisano, Vanda Salutari, Giorgio Valabrega, Domenico Priolo, Sabrina Chiara Cecere, Jole Ventriglia, Francesco Raspagliesi, Francesco Perrone, Anna Fagotti, Domenica Lorusso, Giovanni Scambia, Sandro Pignata
Topics & Concepts
MedicineBevacizumabSerous ovarian cancerSerous fluidOncologyInternal medicineOvarian cancerGynecologyCancerChemotherapyOvarian cancer diagnosis and treatmentPARP inhibition in cancer therapyHER2/EGFR in Cancer Research